This biotechnology company develops portable handheld devices that automate blood testing and diagnostics using digital microfluidic systems. Their technology provides rapid, precise, and accurate results, streamlining workflows for healthcare providers.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional microfluidic development and testing can be complex, time-consuming, and expensive, often requiring specialized equipment and expertise. Automating these processes presents a significant challenge, particularly for organizations lacking in-house microfluidics capabilities. This can hinder innovation and slow down the development of new diagnostic and research tools.
Solution
Blue Ocean Technologies offers digital microfluidics solutions to automate and streamline microfluidic development, testing, and integration. They provide end-to-end support, from initial conceptualization and device design to prototyping and custom software solutions. Their services enable organizations in life sciences, diagnostics, and industrial applications to overcome the limitations of traditional microfluidics and accelerate the development of market-ready solutions. By leveraging their expertise, clients can reduce development time, minimize risks, and achieve more efficient and cost-effective microfluidic workflows.
Target Audience
The primary target audience includes startups, SMEs, and established organizations in life sciences, diagnostics, and industrial applications seeking to automate and improve their microfluidic development processes.
Features
- Digital microfluidic system design and prototyping
- Custom software solutions for microfluidic automation
- End-to-end support for integrating digital microfluidics into existing workflows
- Co-development partnerships for innovative solutions with shared intellectual property rights
- Contract research services for addressing unique microfluidic challenges
- De-risking approach to identify and mitigate risks at every step of development